Adam Koppel, 10% Owner at Arcutis Biotherapeutics, Inc. (ARQT), bought 1,153,690 shares at $17.00 ($5.0M) on 2020-02-04, disclosed to the SEC on 2020-02-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 859,573 | $0 | 0.0% |
| 2 | $17.00 | 294,117 | $5.0M | 100.0% |
| Total | $4.33 avg | 1,153,690 | $5.0M | 100% |
| Filing → |
| SWTX | SELL | 2021-03-11 | $103.7M | — | Filing → |
| DRNA | SELL | 2020-12-14 | $23.4M | — | Filing → |
| CERE | BUY | 2020-11-12 | $6.8M | — | Filing → |